Burr, Murray Statement on Agreement to Reauthorize FDA User Fee Programs, Continue Work on Additional Critical Priorities

Burr, Murray Statement on Agreement to Reauthorize FDA User Fee Programs, Continue Work on Additional Critical Priorities

U.S. Senators Richard Burr (R-NC) and Patty Murray (D-WA), Ranking Member and Chair of the Senate Committee on Health, Education, Labor, and Pensions (HELP), released the following statement on the language they negotiated for passage this week reauthorizing the Food and Drug Administration's (FDA) user fee programs and their commitment to continue working to pass several other bipartisan priorities as part of a larger package later this year.

"We are glad to announce an agreement to reauthorize the FDA user fee programs, which will ensure that FDA can continue its important work and will not need to send out pink slips. However, there is more work ahead this Congress to deliver the kinds of reforms families need to see from FDA, from industry, and from our mental health and pandemic preparedness efforts.

"As part of our agreement, we and our House counterparts are committed to continuing that work, and including strong, bipartisan legislation in a robust end of year package."

Section-by-section of the language included in the continuing resolution is available here.